Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells
- 7 March 2006
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 58 (4) , 540-546
Abstract
Purposes: N-(4-Hydroxyphenyl)-retinamide (4-HPR, Fenretinide) is a synthetic retinoid with cytotoxicity in acute lymphoblastic leukemia (ALL) cell lines. Since ALL is a disease of the bone marrow, a hypoxic tissue compartment, and it has been reported that there is an antagonistic effect of hypoxia on many chemotherapeutic agents, our purpose was to observe whether hypoxia is able to inhibit the effect of 4-HPR for ALL cell lines and to investigate its mechanisms of antagonism to 4-HPR. Methods: Cytotoxicity was measured by MTT method, and apoptosis was measured by flow cytometry. Mitochondrial membrane potential (ΔΨm) was detected by JC1 staining and flow cytometry. Protein expression was analyzed by western blotting. Results: Hypoxia (2% O2) induced 4-HPR resistance in the tested two ALL cell lines (Molt-4 and Molt-3), with at least a 2.8-fold increase in IC50 values (P50 values in normoxia (20% O2). Apoptotic detection showed that 2% O2 significantly suppressed 4-HPR-induced apoptosis and the percentages of 4-HPR-induced apoptotic cells at 12 and 24 h were 1.2 and 11.0%, respectively, compared with 12.6 and 76.3% in 20% O2. In addition, in 20% O2, but not in 2% O2, 4-HPR obviously downregulated the protein expression of procaspase-3, ERK1/2 and XIAP, and increased the cleavage of PARP. Also, a significant ΔΨm loss in response to 4-HPR was observed in normoxia, but not in hypoxia. Conclusions: Hypoxia is able to induce 4-HPR resistance in Molt-4 cells and the mechanism may be involved in the inhibition of 4HPR-induced ΔΨm depolarization and regulation of mitochondrial pathway-related proteins associated in signaling apoptosis.Keywords
This publication has 27 references indexed in Scilit:
- Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytesFree Radical Biology and Medicine, 2005
- Fenretinide Cytotoxicity for Ewing’s Sarcoma and Primitive Neuroectodermal Tumor Cell Lines Is Decreased by Hypoxia and Synergistically Enhanced by Ceramide ModulatorsCancer Research, 2004
- Ceramide synthesis and metabolism as a target for cancer therapyCancer Letters, 2004
- N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytesLeukemia, 2002
- Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaJournal of Clinical Investigation, 2001
- Effector Mechanisms of Fenretinide-Induced Apoptosis in NeuroblastomaExperimental Cell Research, 2000
- Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remissionCancer, 2000
- c-Jun N-Terminal Kinase Mediates Apoptotic Signaling Induced byN-(4-Hydroxyphenyl)retinamideMolecular Pharmacology, 1999
- Retinoic Acid Receptor β Expression and Growth Inhibition of Gynecologic Cancer Cells by the Synthetic Retinoid N-(4-Hydroxyphenyl) RetinamideJNCI: Journal of the National Cancer Institute, 1998
- Bone Marrow Gas Tensions, Bone Marrow Blood Flow, and Erythropoiesis in ManAnnals of Internal Medicine, 1963